H. H. Kazan Et Al. , "Oxford nanopore sequencing-based assay for BTD gene screening: Design, clinical validation, and variant frequency assessment in the Turkish population.," Gene , vol.928, pp.148782, 2024
Kazan, H. H. Et Al. 2024. Oxford nanopore sequencing-based assay for BTD gene screening: Design, clinical validation, and variant frequency assessment in the Turkish population.. Gene , vol.928 , 148782.
Kazan, H. H., Karaca, M., Akan, G., Özgen, Ö., Tuncel, G., Özketen, A. Ç., ... Balcı, M. C.(2024). Oxford nanopore sequencing-based assay for BTD gene screening: Design, clinical validation, and variant frequency assessment in the Turkish population.. Gene , vol.928, 148782.
Kazan, Hasan Et Al. "Oxford nanopore sequencing-based assay for BTD gene screening: Design, clinical validation, and variant frequency assessment in the Turkish population.," Gene , vol.928, 148782, 2024
Kazan, Hasan H. Et Al. "Oxford nanopore sequencing-based assay for BTD gene screening: Design, clinical validation, and variant frequency assessment in the Turkish population.." Gene , vol.928, pp.148782, 2024
Kazan, H. H. Et Al. (2024) . "Oxford nanopore sequencing-based assay for BTD gene screening: Design, clinical validation, and variant frequency assessment in the Turkish population.." Gene , vol.928, p.148782.
@article{article, author={Hasan Hüseyin Kazan Et Al. }, title={Oxford nanopore sequencing-based assay for BTD gene screening: Design, clinical validation, and variant frequency assessment in the Turkish population.}, journal={Gene}, year=2024, pages={148782} }